These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine. Epstein MA, Morgan AJ. Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441 [No Abstract] [Full Text] [Related]
33. Distribution of epitopes within the amino acid sequence of the Epstein-Barr virus major envelope glycoprotein, gp340, recognized by hyperimmune rabbit sera. Pither RJ, Nolan L, Tarlton J, Walford J, Morgan AJ. J Gen Virol; 1992 Jun; 73 ( Pt 6)():1409-15. PubMed ID: 1376768 [Abstract] [Full Text] [Related]
37. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340. Ulaeto D, Wallace L, Morgan A, Morein B, Rickinson AB. Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885 [Abstract] [Full Text] [Related]